Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Autolus Therapeutics	Compugen	Translate Bio	Adaptimmune Therapeutics	Precision BioSciences
Symbol	NASDAQ:AUTL	NASDAQ:CGEN	NASDAQ:TBIO	NASDAQ:ADAP	NASDAQ:DTIL
Price Information
Current Price	$6.35	$8.73	$10.52	$3.04	$5.78
52 Week Range	Buy	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$25.00	$14.50	$20.75	$6.29	$22.17
% Upside from Price Target	293.70% upside	66.09% upside	97.24% upside	106.83% upside	283.51% upside
Trade Information
Market Cap	$215.99 million	$509.73 million	$572.08 million	$342.10 million	$291.55 million
Beta	1.19	2.05	-0.23	1.54	N/A
Average Volume	170,630	1,343,669	548,017	400,638	437,009
Sales & Book Value
Annual Revenue	$2.91 million	$17.80 million	$7.80 million	$1.12 million	$22.24 million
Price / Sales	87.61	33.56	80.96	353.05	13.36
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$6.35 per share	$0.75 per share	$2.56 per share	$1.18 per share	$2.72 per share
Price / Book	1.00	11.64	4.11	2.58	2.13
Profitability
Net Income	$-123,850,000.00	$-27,340,000.00	$-113,290,000.00	$-137,160,000.00	$-92,880,000.00
EPS	($2.88)	($0.43)	($1.84)	($1.32)	($1.91)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-4,258.87%	N/A	-1,451.73%	N/A	-417.65%
Return on Equity (ROE)	-47.61%	-75.28%	-74.44%	-80.93%	-66.96%
Return on Assets (ROA)	-40.32%	-52.01%	-32.10%	-60.98%	-34.32%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.09%	N/A	0.08%	0.19%	N/A
Current Ratio	9.98%	6.60%	4.89%	3.51%	7.19%
Quick Ratio	9.98%	6.60%	4.89%	3.51%	7.19%
Ownership Information
Institutional Ownership Percentage	31.70%	33.74%	86.52%	49.88%	54.34%
Insider Ownership Percentage	N/A	9.50%	15.40%	22.36%	N/A
Miscellaneous
Employees	N/A	89	81	406	127
Shares Outstanding	40.15 million	68.42 million	60.03 million	130.07 million	51.42 million
Next Earnings Date	N/A	5/18/2020 (Estimated)	5/14/2020 (Estimated)	5/4/2020 (Estimated)	5/4/2020 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources